Krishnarathinam Kannan Selected Research

Krishnarathinam Kannan Research Topics

2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 06/2011
1	Multiple Myeloma 01/2023
1	Plasmacytoma 01/2023
1	Immunoglobulin Light-chain Amyloidosis 01/2023
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023
1	Monoclonal Gammopathy of Undetermined Significance 01/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2021
1	Neoplasms (Cancer) 07/2021
1	Leukemia 07/2021
1	Testicular Germ Cell Tumor 04/2021
1	Lymphoma (Lymphomas) 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Invasive Fungal Infections 01/2016

2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2021 - 01/2019
2	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 06/2011
1	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 01/2023
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2019
1	Gemcitabine FDA Link 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Prednisolone (Predate)FDA LinkGeneric 01/2019
1	Voriconazole (Vfend)FDA LinkGeneric 01/2016

2	Therapeutics 01/2019 - 01/2016
1	Hematopoietic Stem Cell Transplantation 07/2021
1	Stem Cell Transplantation 04/2021
1	Drug Therapy (Chemotherapy) 01/2019